原发性肝癌患者血清IL-6、IL-18和IL-18BP检测的意义

doi:10.3969/j.issn.1672-5069.2016.03.027

Abstract

Ye Ming. Changes of serum IL-6，?IL-18?and IL-18 BP levels in patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(3): 354-355.

[1] 官成浓，廖湘晖，罗海清，等. 良恶性原发肝肿瘤患者血IL-18及IL-18BP含量测定及临床意义. 中国肿瘤临床，2009，36（7）：365-367.
[2] Kuppala MB，Syed SB，BandaruS，et al. Immunotherapeutic approach for better management of cancer-role of IL-18. Asian Pac J Cancer Prev，2012，13（11）：5353-5361.
[3] 查翔远，高胜利，吴建成，等. 原发性肝癌患者血清IL-18结合蛋白水平检测及意义. 实用肝脏病杂志，2013，16（6）：552-553.
[4] 范火亮，谢晓贞，刘瑞玉. 原发性肝癌患者血清IL-18、VEGF和sVCAM-1水平变化及临床意义.国际医药卫生导，2012，18（7）：900-902.
[5] Fujita K，Ewing CM，Isaacs WB，et al. Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status.Int J Cancer，2011，129（2）：424-432.
[6] 张春，昊建成.原发性肝癌患者癌组织中IL-18的表达与机体细胞免疫关系研究. 现在实用医学，2011，23（1）：29-31.
[7] 罗福东，丁海明. 肿瘤标志物联检对原发性肝癌诊断的研究进展. 国际医药卫生导报，2010，16（1）：122-124.
[8] 黄承乐，班副植，丁凯宏.原发性肝癌血清TNF-α、IL-2、IL-6和IL-8检测的临床意义.中国误诊学杂志，2011，11（18）：4375-4376.
[9] 张付杰，姜德清. 白细胞介素18在原发性肝癌的临床研究价值.中华全科医学，2012，10（6）：938-939.
[10] 张付杰，姜德清，李大柱，等.联合检测血清IL-6、IL-18及IL-18BP在原发性肝癌中的临床价值.中华全科医学，2012，10（8）：1227-1281.
[11] 郭娜，贾德兴，王万鹏，等.乙型肝炎肝硬化患者血清中IL-18，IL-18BP和IFN-γ的水平变化及临床意义.潍坊医学院学报，2010，32（5）：342-344.
[12] 应雄江. 原发性肝癌患者血清IGF-1、IL-10和IL-18检测的临床意义. 放射免疫学杂志，2013，26（5）：578-579.
[13] 张延强，高美华，张蓓．血清ALP-L3、ICAM-1、IL-18、MMP-9联合检测及对原发性肝癌诊断的临床价值.滨州医学院学报，2013，36（2）：109-111.
[14] 杨焕东，杨桂莲，张春元，等．肝癌患者血清血管内皮生长因子和内皮抑素水平的变化及意.中国全科医学，201l，14（60）：2034-2036．
[15] 贺望娇. 7种肿瘤标志物联合检测对原发性肝癌的诊断价值.国际检验医学杂志，2013，34（6）:734-736.

Changes of serum IL-6，?IL-18?and IL-18 BP levels in patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Jin Juan, Zhou Shoulin, Gao Jing, et al.. Application of dignity therapy combined with psychological intervention in patients with end-stage primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 805-806.
[2]	Song Linquan, Liang Zhihong. Application of high frequency electric knife in hepatectomy in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 637-638.
[3]	Liu Shuhong, Liang Chenge, Xiang Yi, et al. Cost-efficacy of different nucleos(t)ides in the treatment of patients with hepatitis B-related primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 293-294.
[4]	Yi Jinlian, Zuo Lili, Ma Ruijie. Comprehensive nursing intervention in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(2): 299-300.
[5]	He Aijun，Ren Yu.. Splenic management in patients with primary liver cancer underwent hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 571-574.
[6]	Cao Yan, Jiang Feng, Zhang Chao, et al.. Clinical effect of transcatheter hepatic arterial chemoembolization combined with CT-guided precision microwave ablation on patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 468-471.
[7]	Liu Tianbao, Liu Zhanhe, Wu Yuye. Trans-hepatic artery chemoembolization in the treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(4): 507-508.
[8]	Liu Qunyi, Yu Guozheng, Yang Guangning, et al.. Clinical efficacy and safety of cool-tip microwave ablation combining transcatheter arterial chemoembolization in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 316-319.
[9]	Wu Zhenguo, Chen Yongyong, Li Nan. Clinical efficacy of radiofrequency ablation combined with TACE in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 324-327.
[10]	Xu Anbo, Hou Jiliu, Xu Qian. MRI scan and enhanced features of primary liver cancer and focal nodular hyperplasia [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 333-336.
[11]	Dong Jing，Chen Zhaolin，Chen Xi，et al.. Efficacy of TACE combined with CIK cells for the treatment of patients with advanced primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 191-194.
[12]	Zhou Aibin，Zhou Junping，Lu Donghui，et al.. Efficacy of transcatheter arterial chemoembolization combined with three-dimensional conformal radiation therapy in the treatment of patients with massive primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 195-198.
[13]	Song Shuhong，Guo Jun，Zou Can.. Factors influencing postoperative recurrence in patients with primary liver cancer after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 203-206.
[14]	Dai Weiwei, Liu Zhengxin, Xu Baohong. Serum CA125,CA199,AFP,CEA in patients with cirrhosis and primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 81-84.
[15]	Wang Guotai, Yang Xingwu, Wang Qi, et al.. Curative effect of rosin combine with sorafenib in treatment of patients with moderate and advanced primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 614-615.